Natera Inc Share Price Today: Live Updates & Key Insights

Natera Inc share price today is $195.74, up -3.67%. The stock opened at $200.305 against the previous close of $202.73, with an intraday high of $200.98 and low of $194.14.

Natera Inc Share Price Chart

Natera Inc

us-stock
To Invest in {{usstockname}}
us-stock

Natera Inc Share Price Performance

$195.74 -0.0367(-3.67%) NTRA at 23 Mar 2026 02:31 PM Diagnostics & Research
Lowest Today 194.14
Highest Today 200.98
Today’s Open 200.305
Prev. Close 202.73
52 Week High 256.36
52 Week Low 125.38
Day’s Range: Low 194.14 High 200.98
52-Week Range: Low 125.38 High 256.36
1 day return -
1 Week return -1.23
1 month return -6.65
3 month return -17.12
6 month return +8.98
1 year return +27.03
3 year return +250.3
5 year return +87.19
10 year return -

Natera Inc Institutional Holdings

JPMorgan Chase & Co 16.41

Vanguard Group Inc 8.68

T. Rowe Price Associates, Inc. 8.43

BlackRock Inc 7.74

JPMorgan Large Cap Growth I 4.25

JPM US Large Cap Growth-MA 4.09

Wellington Management Company LLP 3.51

Vanguard Total Stock Mkt Idx Inv 2.91

Farallon Capital Management, L.L.C. 2.76

State Street Corp 2.39

Vanguard Small Cap Index 2.10

Franklin Resources Inc 1.88

Coatue Management LLC 1.86

Geode Capital Management, LLC 1.84

AQR Capital Management LLC 1.83

Duquesne Family Office LLC 1.77

Castle Hook Partners LP 1.53

Massachusetts Financial Services Company 1.45

Fred Alger Management, LLC 1.29

NWI Management LP 1.17

Vanguard Small Cap Growth Index Inv 1.16

NORGES BANK 1.15

Sofinnova Ventures 1.09

RTW INVESTMENTS, LLC 1.06

Vanguard Institutional Extnd Mkt Idx Tr 1.05

FMR Inc 1.04

Franklin DynaTech Fund A 1.02

Franklin Innovation Composite 1.02

MFS Mid Cap Growth A 1.00

MFS Mid Cap Growth Equity 1.00

JPMCB Large Cap Growth CF-A 0.81

T. Rowe Price Growth Stock 0.72

American Funds Growth Fund of Amer A 0.70

Capital Group Growth Fnd of Amer Comp 0.70

iShares Biotechnology ETF 0.69

T. Rowe Price US Large-Cap Growth Equity 0.68

T. Rowe Price Lrg Cp Gr I 0.67

US Small-Cap Growth II Equity Comp 0.67

T. Rowe Price US Growth Stock Composite 0.64

T. Rowe Price New Horizons 0.63

Natera Inc Market Status

Strong Buy: 12

Buy: 8

Hold: 0

Sell: 1

Strong Sell: 0

Natera Inc Fundamentals

Market Cap 27677.28 M

PB Ratio 16.7794

PE Ratio 0.0

Enterprise Value 27871.41 M

Total Assets 2508.04 M

Volume 2362767

Natera Inc Company Financials

Annual Revenue FY23:988718000 988.7M, FY22:820222000 820.2M, FY21:625486000 625.5M, FY20:391005000 391.0M, FY19:302328000 302.3M

Annual Profit FY23:422842000 422.8M, FY22:363966000 364.0M, FY21:307068000 307.1M, FY20:187385000 187.4M, FY19:126858000 126.9M

Annual Net worth FY23:-499343000 -499.3M, FY22:-547799000 -547.8M, FY21:-471716000 -471.7M, FY20:-229743000 -229.7M, FY19:-124827000 -124.8M

Quarterly Revenue Q3/2025:592183000 592.2M, Q2/2025:546600000 546.6M, Q1/2025:501830000 501.8M, Q3/2024:439758000 439.8M, Q2/2024:413351000 413.4M

Quarterly Profit Q3/2025:384382000 384.4M, Q2/2025:347069000 347.1M, Q1/2025:317217000 317.2M, Q3/2024:271747000 271.7M, Q2/2024:243172000 243.2M

Quarterly Net worth Q3/2025:-87544000 -87.5M, Q2/2025:-100938000 -100.9M, Q1/2025:-66936000 -66.9M, Q3/2024:-31592000 -31.6M, Q2/2024:-37464000 -37.5M

About Natera Inc & investment objective

Company Information Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.

Organisation Diagnostics & Research

Employees 6135

Industry Diagnostics & Research

CEO Mr. Steven Leonard Chapman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Natera Inc FAQs

What is the share price of Natera Inc today?

The current share price of Natera Inc is $195.74.

Can I buy Natera Inc shares in India?

Yes, Indian investors can buy Natera Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Natera Inc shares in India?

You can easily invest in Natera Inc shares from India by:

Can I buy fractional shares of Natera Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Natera Inc?

Natera Inc has a market cap of $27677.28 M.

In which sector does Natera Inc belong?

Natera Inc operates in the Diagnostics & Research sector.

What documents are required to invest in Natera Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Natera Inc?

The PE ratio of Natera Inc is N/A and the PB ratio is 16.78.